NEUROMYELITIS OPTICA SPECTRUM DISORDER: CLINICAL CASE REPORT WITH HYPONATREMIA DUE TO DAMAGE TO THE DIENCEPHALON

Văn Tuận Nguyễn, Công Tấn Nguyễn, Thị Mai Hương Nguyễn

Main Article Content

Abstract

Background: Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune inflammatory disease of the central nervous system, often occurring in young people. The anti-aquaporin 4 antibodies cause damage to the optic nerve, spinal cord, and brain. Early diagnosis of atypical cases that it's only damage the brain remains a major challenge. Case report: A 16-year-old female patient was treated at the Intensive Care Center of Bach Mai Hospital from June 15, 2021, to July 7, 2021, and discharged from the hospital. Her first illness occurred one week before admission to the hospital. The disease has an acute onset with vomiting, consciousness disorders, narcolepsy, mental disorders, hyponatremia (first time 105 mmol/l), brain magnetic resonance with damage to the diencephalon, and in the cerebrospinal fluid, there are 40 white cells/mm3, increased mainly lymphocytes, and IgG-AQP4 (+). After diagnosis and treatment, the patient recovered well. Conclusion: NMOSD is a rare disorder and thoroughly atypical, but magnetic resonance imaging has characteristic lesions of NMOSD, requiring IgG-NMO testing and early treatment to limit sequelae for the patient.

Article Details

References

1. Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015; 85(2): 177-89.
2. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364(9451): 2106-12.
3. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17(2): 162-73.
4. Papp V, Magyari M, Aktas O, et al. Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review. Neurology 2021; 96(2): 59-77.
5. Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol 2014; 170(3): G1-47.
6. Alvarez RM, Leon ZS, Cuascut F, et al. Rheumatic Diseases Associated with Neuromyelitis Optica Spectrum Disorders (NMOSD): Prevalence, Clinical, Laboratory and Imaging Characteristics [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9).
7. Wang L, Zhou L, ZhangBao J, et al. Causal associations between prodromal infection and neuromyelitis optica spectrum disorder: A Mendelian randomization study. Eur J Neurol 2023; 30(12): 3819-27.
8. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006; 63(7): 964-8.
9. Nakashima I, Fujihara K, Miyazawa I, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006; 77(9): 1073-5.
10. Suzuki K, Nakamura T, Hashimoto K, et al. Hypothermia, hypotension, hypersomnia, and obesity associated with hypothalamic lesions in a patient positive for the anti-aquaporin 4 antibody: a case report and literature review. Arch Neurol 2012; 69(10): 1355-9.